SPERMOSENS RIGHTS ISSUE NOW ACTIVE – SUBSCRIPTION PERIOD FROM 9 TO 23 JANUARY. READ MORE HERE.

UPCOMING TRANSACTION

Brain+ to commence a Rights Issue with 85% 
secured already.

Brain+ [BRAINP] plans to raise DKK 15.7 million, and the subscription period for the Rights Issue is tentatively scheduled for May 2023, subject to approval.

COMPELETED TRANSACTION

We are pleased to announce that DecideAct has completed their Directed Issue.

Brain+ [BRAINP] plans to raise DKK 15.7 million, and the subscription period for the Rights Issue is tentatively scheduled for May 2023, subject to approval.

WHO WE ARE

Financial and Strategic advisors to future market leaders.

We work to benefit both stakeholders and society by working with ‘Gemstone’ growth companies
with market leader potential.

0
IPO'S AND
COUNTING
0
+
TRANSACTIONS
IN TOTAL
0
DKK MILLION
RAISED
0
%
AVG ROI SINCE
INCEPTION
WHAT WE DO

We provide a combination of competence
and capital as required, case by case.

We focus on quality and value creation, no matter if you are an IPO candidate
or a company with a desire to buy or sell strategic assets.

FEATURED GEMSTONES

Gemstones are high quality, ambitious companies, run by a strong
and passionate team.

realfiction2

REALFICTION

A leading provider of mixed reality displays and a ground-breaking new 3D-display technology, offering next-generation TVs with real 3D.

stenocareimgage

STENOCARE

Leading medical cannabis brand with multiple licenses to sell prescription-based products in several countries and an indoor facility to produce the highest quality oil products.

expres2ionslider

EXPRES2ION BIOTECH

A life science platform company with technology that enables the development of vaccines for diseases such as COVID-19, malaria, and breast cancer.

Brain-APP-in-phone-used-by-elder

BRAIN+

Developer and provider of clinically validated products for Alzheimer’s and Dementia in partnership with leading universities and pharma companies

Screenshot 2023-01-06 at 13.51.05

DECIDEACT

DecideAct help leaders modernize their leadership through technology. Their focus is to help management placing strategy execution at the core of their business.

spermosens-spermcell-egg-1200x900

SPERMOSENS

A leading developer of Male Fertility Medical Devices with a goal is to improve male fertility diagnostics and treatment through ground-breaking products.

WHO WE ARE

There is a lot going on. Some of it we can proudly announce upon completion,
but most of what we do with clients is bound by non-disclosure and insider restrictions.

DEC 21

Freetrailer spotted by Nordnet as best share in Denmark in 2021 with 354% return

DEC 21

Freetrailer spotted by Nordnet as best share in Denmark in 2021 with 354% return

DEC 21

Freetrailer spotted by Nordnet as best share in Denmark in 2021 with 354% return

DEC 21

Freetrailer spotted by Nordnet as best share in Denmark in 2021 with 354% return